US Armed Forces Inst of Regenerative Medicine award

UK regenerative medicines firm Intercytex says that it is part of a group that have been selected to establish the USA' Armed Forces Institute of Regenerative Medicine, supported by a foundation grant from the US government totalling $85.0 million. The purpose of AFIRM is to use the science of regenerative medicine to develop new treatments for battlefield injuries. Therapies developed by the AFIRM will also be used in trauma and burns patients in the general public.

The AFIRM is a multi-institutional, interdisciplinary network developing advanced treatment options for severely wounded soldiers. It is managed and funded via the US Army Medical Research and Materiel Command, with additional funding from the Office of Naval Research, the Air Force Office of the Surgeon General, the National Institutes of Health, the Department of Veterans Affairs, as well as local public and private matching funding. It is made up of two civilian research consortia working with the US Army Institute for Surgical Research. One is led by the McGowan Institute for Regenerative Medicine and the Wake Forest Institute for Regenerative Medicine and the other is led by Rutgers, the State University of New Jersey and the Cleveland Clinic.